Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Lecithinized Superoxide Dismutase Nebulizer (PC-SOD NE) in Adult Patients with Moderate Idiopathic Pulmonary Fibrosis
Latest Information Update: 16 Jul 2025
At a glance
- Drugs LT 0011 (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- Sponsors LTT Bio-Pharma
Most Recent Events
- 16 Jul 2025 New trial record